Please assess the completion status of the following clinical trial:

Trial Title: Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Target aneurysm is an unruptured wide-neck, intracranial, saccular anterior circulation aneurysm (≤ 10 mm) arising from a parent vessel with a diameter of ≥ 2.5 mm and ≤ 4 mm~* Subject understands the nature of the procedure and provides voluntary written informed consent prior to the treatment~* Subject is willing to comply with specified follow-up evaluation~Exclusion Criteria:~* Planned staged procedure~* Currently enrolled in another investigational device or drug study~* Target aneurysm that has been previously treated~* Mycotic, fusiform or dissecting aneurysm~* Admission platelet \<50,000 or any known hemorrhagic diathesis, coagulation deficiency, or on oral anticoagulant therapy with an INR \>3.0~* A serum creatinine level \> 2.5 mg/dL within 7 days prior to index procedure

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Enterprise (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).